Literature DB >> 20626032

Upstream stimulatory factor-2 mediates quercetin-induced suppression of PAI-1 gene expression in human endothelial cells.

Nélida C Olave1, Maximiliano H Grenett, Martin Cadeiras, Hernan E Grenett, Paul J Higgins.   

Abstract

The polyphenol quercetin (Quer) represses expression of the cardiovascular disease risk factor plasminogen activator inhibitor-1 (PAI-1) in cultured endothelial cells (ECs). Transfection of PAI-1 promoter-luciferase reporter deletion constructs identified a 251-bp fragment (nucleotides -800 to -549) responsive to Quer. Two E-box motifs (CACGTG), at map positions -691 (E-box1) and -575 (E-box2), are platforms for occupancy by several members of the c-MYC family of basic helix-loop-helix leucine zipper (bHLH-LZ) proteins. Promoter truncation and electrophoretic mobility shift/supershift analyses identified upstream stimulatory factor (USF)-1 and USF-2 as E-box1/E-box2 binding factors. ECs co-transfected with a 251 bp PAI-1 promoter fragment containing the two E-box motifs (p251/luc) and a USF-2 expression vector (pUSF-2/pcDNA) exhibited reduced luciferase activity versus p251/luc alone. Overexpression of USF-2 decreased, while transfection of a dominant-negative USF construct increased, EC growth consistent with the known anti-proliferative properties of USF proteins. Quer-induced decreases in PAI-1 expression and reduced cell proliferation may contribute, at least in part, to the cardioprotective benefit associated with daily intake of polyphenols.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20626032      PMCID: PMC3521593          DOI: 10.1002/jcb.22760

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  42 in total

1.  The upstream stimulatory factor-2a inhibits plasminogen activator inhibitor-1 gene expression by binding to a promoter element adjacent to the hypoxia-inducible factor-1 binding site.

Authors:  A Samoylenko; U Roth; K Jungermann; T Kietzmann
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

2.  Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells.

Authors:  L H Abou-Agag; M L Aikens; E M Tabengwa; R L Benza; S R Shows; H E Grenett; F M Booyse
Journal:  Alcohol Clin Exp Res       Date:  2001-02       Impact factor: 3.455

3.  DNA-binding activity of the transcription factor upstream stimulatory factor 1 (USF-1) is regulated by cyclin-dependent phosphorylation.

Authors:  E Cheung; P Mayr; F Coda-Zabetta; P G Woodman; D S Boam
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

4.  Identification of a 251-bp fragment of the PAI-1 gene promoter that mediates the ethanol-induced suppression of PAI-1 expression.

Authors:  H E Grenett; P E Wolkowicz; R L Benza; J K Tresnak; C G Wheeler And; F M Booyse
Journal:  Alcohol Clin Exp Res       Date:  2001-05       Impact factor: 3.455

5.  Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects.

Authors:  A Pandolfi; D Cetrullo; R Polishuck; M M Alberta; A Calafiore; G Pellegrini; E Vitacolonna; F Capani; A Consoli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-08       Impact factor: 8.311

6.  Ethanol downregulates transcription of the PAI-1 gene in cultured human endothelial cells.

Authors:  H E Grenett; M L Aikens; E M Tabengwa; G C Davis; F M Booyse
Journal:  Thromb Res       Date:  2000-02-15       Impact factor: 3.944

7.  Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.

Authors:  K Kaikita; A B Fogo; L Ma; J A Schoenhard; N J Brown; D E Vaughan
Journal:  Circulation       Date:  2001-08-14       Impact factor: 29.690

8.  Quercetin inhibits human vascular smooth muscle cell proliferation and migration.

Authors:  Francisco Alcocer; David Whitley; Jesus F Salazar-Gonzalez; William D Jordan; Marty T Sellers; Devin E Eckhoff; Kaori Suzuki; Chastity Macrae; Kirby I Bland
Journal:  Surgery       Date:  2002-02       Impact factor: 3.982

9.  Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries.

Authors:  M B DeYoung; C Tom; D A Dichek
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

Review 10.  Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.

Authors:  Rohan Samarakoon; Paul J Higgins
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

View more
  11 in total

1.  Investigation of the Potential Mechanism Governing the Effect of the Shen Zhu San on COVID-19 by Network Pharmacology.

Authors:  Yuxuan Wang; Yuhua Ru; Guowei Zhuo; Maozheng Sheng; Shuangqiu Wang; Jiarui Ma; Chongyi Zhou; Xiaohe Sun; Yanqi Zeng; Ya Zhang; Hui Li; Zhigang Lu; Depei Wu; Minghua Wu
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-07       Impact factor: 2.629

2.  Upstream stimulatory factors 1 and 2 mediate the transcription of angiotensin II binding and inhibitory protein.

Authors:  Miyuki Matsuda; Kouichi Tamura; Hiromichi Wakui; Akinobu Maeda; Masato Ohsawa; Tomohiko Kanaoka; Kengo Azushima; Kazushi Uneda; Sona Haku; Yuko Tsurumi-Ikeya; Yoshiyuki Toya; Yohei Maeshima; Akio Yamashita; Satoshi Umemura
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

3.  Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer.

Authors:  Tina Horbach; Claudia Götz; Thomas Kietzmann; Elitsa Y Dimova
Journal:  Front Pharmacol       Date:  2015-02-18       Impact factor: 5.810

4.  The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.

Authors:  Yi Zhu; Tamara Tchkonia; Tamar Pirtskhalava; Adam C Gower; Husheng Ding; Nino Giorgadze; Allyson K Palmer; Yuji Ikeno; Gene B Hubbard; Marc Lenburg; Steven P O'Hara; Nicholas F LaRusso; Jordan D Miller; Carolyn M Roos; Grace C Verzosa; Nathan K LeBrasseur; Jonathan D Wren; Joshua N Farr; Sundeep Khosla; Michael B Stout; Sara J McGowan; Heike Fuhrmann-Stroissnigg; Aditi U Gurkar; Jing Zhao; Debora Colangelo; Akaitz Dorronsoro; Yuan Yuan Ling; Amira S Barghouthy; Diana C Navarro; Tokio Sano; Paul D Robbins; Laura J Niedernhofer; James L Kirkland
Journal:  Aging Cell       Date:  2015-04-22       Impact factor: 9.304

Review 5.  Finding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging Molecules.

Authors:  Surinder Kumar; David B Lombard
Journal:  F1000Res       Date:  2016-03-29

6.  The Synergistic Effect of Plasminogen Activator Inhibitor-1 (PAI-1) Polymorphisms and Metabolic Syndrome on Coronary Artery Disease in the Korean Population.

Authors:  Han Sung Park; Jung-Hoon Sung; Chang Soo Ryu; Jeong Yong Lee; Eun Ju Ko; In Jai Kim; Nam Keun Kim
Journal:  J Pers Med       Date:  2020-11-28

Review 7.  Therapeutic Potential of Senolytics in Cardiovascular Disease.

Authors:  Emily Dookun; João F Passos; Helen M Arthur; Gavin D Richardson
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-26       Impact factor: 3.727

Review 8.  Senolytics: Potential for Alleviating Diabetes and Its Complications.

Authors:  Allyson K Palmer; Tamar Tchkonia; James L Kirkland
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 4.736

9.  Regulatory network changes between cell lines and their tissues of origin.

Authors:  Camila M Lopes-Ramos; Joseph N Paulson; Cho-Yi Chen; Marieke L Kuijjer; Maud Fagny; John Platig; Abhijeet R Sonawane; Dawn L DeMeo; John Quackenbush; Kimberly Glass
Journal:  BMC Genomics       Date:  2017-09-12       Impact factor: 3.969

Review 10.  Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls.

Authors:  W Andrew Owens; Anna Walaszczyk; Ioakim Spyridopoulos; Emily Dookun; Gavin D Richardson
Journal:  Mech Ageing Dev       Date:  2021-07-06       Impact factor: 5.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.